AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Patient Recruitment.
Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.
Patient Recruitment Industry Benchmarks
The average annual savings achieved in Patient Recruitment category is 8.17%
The industry average payment terms in Patient Recruitment category for the current quarter is 68.8 days
Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™
Category Strategy and Flexibility
Price per Unit Competitiveness
Minimum Order Quality
The World’s first Digital Market Analyst
The World’s first Digital Market Analyst
Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions
Patient Recruitment Suppliers
Find the right-fit patient recruitment supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.
Use the Patient Recruitment market, supplier and price information for category strategy creation and Quaterly Business Reviews (QRBs)
Patient Recruitment market report transcript
Patient Recruitment Global Market Outlook
The global demand is expected to be $8.2–8.6 Billion in 2021 and will grow at approx. 12—15 percent CAGR through 2020–2026
Focus on biologics, personalized medicine, and increasing complexity, in terms of protocol, study procedures, trial design, and globalization of clinical trials demanding regional regulatory compliance are the major factors driving the market
Availability of a large patient pool, coupled with cost-saving opportunity, due to reduced labor wage, is shifting the focus to the emerging nations
Large CROs have been continuously expanding their supply base through acquisitions and partnerships to provide integrated services
Of the site investigators, 52 percent expect a change in site models that is more inclusive of pharmacies and local or pop-up clinics
Impact of COVID-19 on Patient Recruitment Industry
Implementation of patient-centric approaches and decentralized trials increased, owing to pandemic necessitating use of new technologies for trial success.
Diversity in clinical trials surfaced, owing to vaccine trials and now has become integral part of patient recruitment processes
Use of technologies, like eConsent/eCOA, ePRO, mobile devices, wearables, insertables, telemedicine has increased to enable DCT trials.
CROs are converting approx. 60 percent of their visits to remote monitoring
Approaches, like online recruitment, home nursing, and direct-to patient trial supply have been adopted to ensure patient safety and trial continuity
75 percent of the organizations are in some stage of implementing virtual trials
Procurement Centric Five Forces Analysis on Patient Recruitment Industry
Suppliers–Established and emerging currently view large pharma as a key account. The attractiveness of a pharma client is high, as they bring in high purchase orders, good payment terms, and greater brand visibility. This acts as an enabler to move the accounts into a supplier's core business area.
Along with CROs and PROs suppliers in this industry comprises of hospitals and physicians, patient advocacy groups and focus groups, who directly communicate to the patients about the clinical trials. Patients are increasingly dependent on these means to enroll in clinical trials
Focus on rare disease and precision medicine have created more challenges to recruit patients and hence, digital players with access to wide patient data are gaining traction compared to traditional suppliers, thus keeping overall supplier power medium
Barriers to New Entrants
Increased regulatory demand, varying regional regulatory compliance, as well as the cost associated with advertisement campaigns, database management, site management, clinical procedure and central lab make it more difficult for suppliers to pose competition to large suppliers
Advancement in AI and ML techniques has paved the way for new era of digital suppliers
Intensity of Rivalry
The patient recruitment market is a highly fragmented market with CROs, PROs and niche players trying to gain market share
As the industry is trying to move towards digital trial recruitment, suppliers are trying to acquire tech oriented niche players to expand their capabilities in the digital field
Threat of Substitutes
With the increase in adoption of Real world Evidence data, demand for supplier with access to advanced technology and access to patient data is increasing. Hence, suppliers focusing on newer tactics are emerging and posing competition to traditional players
With the increase in PoCs, wearables and direct-to-patient initiatives, including patient communities voluntary trial selection by patients might be feasible
This will cause instability among the suppliers in the market
There is intense competition among sponsors to recruit appropriate quality patients on time
The supplier market is fragmented with multiple suppliers, who cater to several big pharmaceutical companies and provide a range of services associated with patient recruitment and retention
Pharma companies have a greater choice and ability to switch between suppliers, however, the intense demand for patients keeps the power moderate to high especially in rare therapeutic areas and oncology